UroGen Pharma Ltd. (URGN) › Net IncomeUroGen Pharma Ltd. (URGN) — Net IncomeAnnual figures by period end, from SEC filings.2015-12-31: -$12.69M2016-12-31: -$1.94M2017-12-31: -$20.00M2018-12-31: -$75.66M2019-12-31: -$105.15M2020-12-31: -$128.48M2021-12-31: -$110.82M2022-12-31: -$109.78M2023-12-31: -$102.24M2024-12-31: -$126.87M2025-12-31: -$153.49M-$153.49M2015-12-31Net Income (USD)2025-12-31Period endedNet IncomeChange YoYSource filing2025-12-31-$153.49M—2026-03-02From 2025-01-012024-12-31-$126.87M—2026-03-02From 2024-01-012023-12-31-$102.24M—2025-03-10From 2023-01-012022-12-31-$109.78M—2024-03-14From 2022-01-012021-12-31-$110.82M—2023-03-24From 2021-01-012020-12-31-$128.48M—2022-03-21From 2020-01-012019-12-31-$105.15M—2021-03-18From 2019-01-012018-12-31-$75.66M—2020-03-02From 2018-01-012017-12-31-$20.00M—2020-03-02From 2017-01-012016-12-31-$1.94M—2019-02-28From 2016-01-012015-12-31-$12.69M—2018-03-15From 2015-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)